Literature DB >> 17235006

Pathologic and MR imaging features of benign fibrous soft-tissue tumors in adults.

Philip A Dinauer1, Clark J Brixey, Joel T Moncur, Julie C Fanburg-Smith, Mark D Murphey.   

Abstract

Benign fibrous (fibroblastic or myofibroblastic) soft-tissue tumors are a heterogeneous group of fibrous lesions with widely varied anatomic locations, biologic behavior, and pathologic features. The four broad categories of fibrous proliferation are benign fibrous proliferations, fibromatoses, fibrosarcomas, and fibrous proliferations of infancy and childhood. The first two categories include nonaggressive fibroblastic lesions such as nodular fasciitis, as well as fibromatoses that demonstrate more aggressive biologic behavior (eg, desmoid tumors). In adults, fibrous tumors are among the most common soft-tissue lesions encountered in clinical practice. MR imaging can be useful for defining the intrinsic signal characteristics, size, and compartmental extension of these lesions. Histologic features of the tumor also may be depicted on T2-weighted MR images. Hypocellular fibrous tumors with dense collagenous components tend to have lower signal intensity on T2-weighted images than do lesions that are more cellular or that contain greater amounts of extracellular myxoid matrix. When interpreting MR images of soft-tissue masses in adults, radiologists should be aware of the clinical behavior, common sites of occurrence, and histopathologic and imaging features of the common benign fibrous soft-tissue tumors.

Entities:  

Mesh:

Year:  2007        PMID: 17235006     DOI: 10.1148/rg.271065065

Source DB:  PubMed          Journal:  Radiographics        ISSN: 0271-5333            Impact factor:   5.333


  60 in total

1.  Gardner syndrome complicated with hydronephrosis. A case report.

Authors:  Paolo Cabassa; Mario Morone; Enza Gatti; Mariapaola Narbone; Roberto Maroldi
Journal:  J Radiol Case Rep       Date:  2010-03-01

2.  [Imaging and biopsy of soft tissue tumors].

Authors:  L Fenzl; K Bubel; M Mehrmann; G Schneider
Journal:  Radiologe       Date:  2018-01       Impact factor: 0.635

3.  Retroperitoneal nodular fasciitis: a benign etiology on the differential diagnosis of malignant gastric outlet obstruction.

Authors:  C Andrew Kistler; Wei Jiang; Robert M Coben
Journal:  J Gastrointest Oncol       Date:  2015-04

Review 4.  Imaging of superficial and deep fibromatosis.

Authors:  G Guglielmi; A Cifaratti; G Scalzo; N Magarelli
Journal:  Radiol Med       Date:  2009-09-30       Impact factor: 3.469

Review 5.  [Imaging characteristics of malignant and benign lesions of skeletal muscle].

Authors:  L Leonard; H J Meyer; A Surov
Journal:  Radiologe       Date:  2017-12       Impact factor: 0.635

Review 6.  Benign soft-tissue lesions of the fingers: radiopathological correlation and clinical considerations.

Authors:  Roque Oca Pernas; Raquel Prada González; Eloísa Santos Armentia; Nerea Hormaza Aguirre; Gonzalo Tardáguila de la Fuente; Carmen Trinidad López; Carlos Delgado Sánchez-Gracián
Journal:  Skeletal Radiol       Date:  2014-11-01       Impact factor: 2.199

7.  Lumps and bumps around the foot and ankle: an assessment of frequency with ultrasound and MRI.

Authors:  Akash Ganguly; Hifz Aniq; Bill Skiadas
Journal:  Skeletal Radiol       Date:  2013-02-06       Impact factor: 2.199

8.  Soft tissue extramedullary plasmacytoma.

Authors:  Fernando Ruiz Santiago; Manuel Tello Moreno; Aurelio Martín Castro; Luis Guzmán Alvarez; Pedro Navarrete González
Journal:  Case Rep Med       Date:  2010-03-03

9.  Myxofibrosarcoma: prevalence and diagnostic value of the "tail sign" on magnetic resonance imaging.

Authors:  Robert A Lefkowitz; Jonathan Landa; Sinchun Hwang; Emily C Zabor; Chaya S Moskowitz; Narasimhan P Agaram; David M Panicek
Journal:  Skeletal Radiol       Date:  2013-01-15       Impact factor: 2.199

10.  Appearance of abdominal wall endometriosis on MR imaging.

Authors:  Milou P H Busard; Velja Mijatovic; Cees van Kuijk; Peter G A Hompes; Jan Hein T M van Waesberghe
Journal:  Eur Radiol       Date:  2009-11-21       Impact factor: 5.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.